Advertisement
OtherMinireview

Adverse Drug Reactions and Toxicity of the FDA-approved Antisense Oligonucleotide Drugs

Feryal Alhamadani, Kristy Zhang, Rajvi Parikh, Hangyu Wu, Theodore P Rasmussen, Raman Bahal, Xiao-bo Zhong and Jose E. Manautou PhD
Drug Metabolism and Disposition February 27, 2022, DMD-MR-2021-000418; DOI: https://doi.org/10.1124/dmd.121.000418
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherMinireview

Safety of Antisense Oligonucleotide Drugs

Feryal Alhamadani, Kristy Zhang, Rajvi Parikh, Hangyu Wu, Theodore P Rasmussen, Raman Bahal, Xiao-bo Zhong and Jose E. Manautou
Drug Metabolism and Disposition February 27, 2022, DMD-MR-2021-000418; DOI: https://doi.org/10.1124/dmd.121.000418
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement